Cite
HARVARD Citation
Jiang, L. et al. (2022). A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants. Journal of extracellular vesicles. 11 (3), p. n/a. [Online].